Duos Technologies Featured Sponsor at Rail Insights 2024
13 juin 2024 08h00 HE
|
Duos Technologies Group, Inc
Duos Technologies Featured Sponsor at Rail Insights 2024
Tevogen Bio Enters Into Agreement for Up to $50 Million in Financing to Advance R&D and Clinical Development Efforts
11 juin 2024 15h30 HE
|
Tevogen Bio Inc
Agreement for Up to $50 Million in Financing. Includes $36 million line of credit and potential $14 million private placement.
Anaqua Annual User Experience Conference to Feature Keynotes from Microsoft, SAP, USPTO, and More
30 mai 2024 08h00 HE
|
Anaqua
IP Management software company Anaqua today announces a lineup of IP speakers and panelists for its 15th annual Anaqua Experience Conference (AEC).
Groundbreaking Technology Solves Major Problem of User Lockouts During MFA Resets
30 mai 2024 08h00 HE
|
NAMETAG INC.
Nametag patents breakthrough technology that eliminates frustration and security risks associated with resetting multi-factor authentication tokens.
CarbonMeta Technologies Files Provisional Patent for Tracking Captured CO2 in Concrete Using Blockchain Technology
28 mai 2024 08h30 HE
|
CarbonMeta Technologies, Inc.
Woodinville, WA, USA, May 28, 2024 (GLOBE NEWSWIRE) -- CarbonMeta Technologies Inc. (OTC PINK:COWI, “CarbonMeta”), a pioneering green technology company, today announced the filing of a...
Rail Vision Received Notice of Allowance for US Patent on AI-Powered Railway Obstacle Detection System
21 mai 2024 09h19 HE
|
Rail Vision Ltd.
Ra’anana, Israel, May 21, 2024 (GLOBE NEWSWIRE) -- Rail Vision Ltd. (Nasdaq: RVSN) (the “Company”), a technology company at the forefront of revolutionizing railway safety and the data-related...
U.S. Patent and Trademark Office Grants US Patent # 11,975,112 for “Treatment of Vomiting and Nausea with Minimum Dose of Olanzapine”
20 mai 2024 10h36 HE
|
Starton Therapeutics
Olanzapine (ZYPREXA®) is an antipsychotic medication used to treat schizophrenia and bipolar disorder that is commonly used as anti-nausea off label medication.Olanzapine has been investigated for use...
AB Science annonce la délivrance d’un brevet européen pour le masitinib dans le traitement de la mastocytose sévère avec une protection jusqu’en 2036
13 mai 2024 12h08 HE
|
AB Science
COMMUNIQUE DE PRESSE AB SCIENCE ANNONCE LA DÉLIVRANCE D'UN BREVET EUROPÉEN POUR LE MASITINIB DANS LE TRAITEMENT DE LA MASTOCYTOSE SÉVÈRE AVEC UNE PROTECTION JUSQU'EN 2036 ...
AB Science announces issuance of a European patent for masitinib in the treatment of severe mastocytosis with protection until 2036
13 mai 2024 12h08 HE
|
AB Science
PRESS RELEASE AB SCIENCE ANNOUNCES ISSUANCE OF A EUROPEAN PATENT FOR MASITINIB IN THE TREATMENT OF SEVERE MASTOCYTOSIS WITH PROTECTION UNTIL 2036 Paris, May 13, 2024, 6pm CET AB Science SA...
Anaqua présente la version 8 de PATTSY WAVE, son logiciel de gestion de la propriété intellectuelle
07 mai 2024 08h00 HE
|
Anaqua
BOSTON, 07 mai 2024 (GLOBE NEWSWIRE) -- Anaqua, leader des technologies de gestion de la propriété intellectuelle (PI) et de l’innovation, lance dès aujourd’hui la version 8 de PATTSY WAVE. Il...